Health Care & Life Sciences » Pharmaceuticals » Johnson & Johnson | Revenue of Johnson & Johnson's pharmaceuticals segment worldwide 2012-2024

Revenue of Johnson & Johnson's pharmaceuticals segment worldwide 2012-2024

Revenue of Johnson & Johnson's pharmaceuticals segment worldwide from 2012 to 2024, by product category (Figures expressed in billions of U.S. dollars, unless otherwise specified)

The data displays the revenue share of Johnson & Johnson's pharmaceuticals segment worldwide from 2012 to 2024, by product category. Johnson & Johnson is a multi-national company, specialized on pharmaceuticals, medical devices and consumer goods. The company is headquartered in New Brunswick, New Jersey. In 2017, Johnson & Johnson's anti-infectives segment global revenue amounted to 3.15 billion USD.

2012 7.87 4.94 2.63 6.72 3.19
2013 9.19 4.95 3.77 6.67 3.55
2014 10.19 5.58 4.46 6.49 5.6
2015 10.4 6.42 4.7 6.26 3.66
2016 11.97 6.4 5.81 6.08 3.21
2017 12.24 6.29 7.26 5.99 3.15
2018 12.34 7.19 8.96 5.74 3.18
2019 12.49 7.27 988 4.93 3.79
2020 12.09 7.1 10.73 4.84 3.95
2021 11.69 7.09 11.78 4.94 4.38
2022 11.14 6.93 12.71 5.05 5.02
2023 10.24 6.8 13.91 4.68 5.45
2024 9.34 6.79 14.86 5.03 5.94

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.